Jun 26, 2026 · 7 min
Biotech deal lifts one stock as AI bets unsettle two others
Onsemi, Oracle End Week Lower, Biotechne Jumps
The episode shows how acquisitions, debt worries and IPO uncertainty can quickly reshape investor sentiment across technology and life sciences.
- 1Onsemi’s $7 billion Synaptics acquisition deepened its physical AI and robotics push while sending shares toward their worst week since 2008.
- 2Bio-Techne surged after Germany’s Merck agreed to acquire the life sciences company for $11.3 billion.
- 3Oracle fell as debt concerns combined with reports that partner OpenAI could delay its initial public offering.
Don't miss
Bio-Techne’s $11.3 billion acquisition agreement with Germany’s Merck produced the episode’s strongest market reaction.
The brief
Bloomberg Radio’s Stock Movers report, hosted by Nora Melinda with senior equities reporter Just Minton, tracks three sharp market reactions across semiconductors, life sciences and cloud technology.
Onsemi suffered its worst week since 2008 after announcing a $7 billion acquisition of Synaptics, a deal meant to expand its push into physical AI and robotics.
Bio-Techne delivered the episode’s clearest upside surprise, posting its best week since 2003 after Germany’s Merck agreed to acquire the life sciences company for $11.3 billion.
Oracle’s decline shows the other side of AI exposure: debt concerns and reports that partner OpenAI could delay its initial public offering weighed on the stock.
Together, the moves show investors distinguishing between a concrete takeover premium and longer-term AI strategies whose financing and timing remain uncertain.
What was said on this episode
7 statements · 4 positive · 3 negative
ON Semiconductor shares fell 25% this week.
“the stock's down 25%”
Listen at 1:21
ON Semiconductor had its worst stock week since November 2008.
“that would be its worst week since November 2008”
Listen at 1:24
The ON Semiconductor-Synaptics acquisition is expected to close in mid-2027.
“it basically expects this deal to potentially close in mid-2027”
Listen at 2:42
Bio-Techne shares rose almost 23% this week.
“this was actually up almost 23% this week”
Listen at 3:37
Bio-Techne had its best stock week since May 2003.
“best week since May of 2003”
Listen at 3:44
Germany’s Merck acquired Bio-Techne for more than $11 billion.
“it bought this company basically if you're looking for over $11 billion”
Listen at 4:12
Oracle shares could experience more volatility from uncertainty over OpenAI’s IPO timeline.
“there could be more volatility because of the back and forth with the timeline”
Listen at 5:21
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
S&P 500
Artificial IntelligenceListen to the full episode and explore every guest, topic, and moment on PodLume.